DrugsControl Media Services
DrugsControl.org

News Detail

Delhi High Court rejects AstraZeneca’s plea on Dapagliflozin drug patent (19-11-2020)

Mumbai, 19 Nov 2020: The Delhi high court has rejected global pharma major AstraZeneca’s application seeking a restraining order against marketing of a blockbuster anti-diabetes drug Dapagliflozin by domestic companies, including Torrent, USV, Micro Labs, Eris LifeSciences ......
View Details

Source : The Times of India

Related News